<DOC>
	<DOCNO>NCT00845026</DOCNO>
	<brief_summary>This study assess time discontinuation due lack tolerability among patient schizophrenia receive LY2140023 , give orally twice daily 24 week , versus atypical antipsychotic standard-of-care treatment . Lack tolerability define discontinuation due adverse event ( AEs ) . Patients complete active treatment phase eligible continue optional 28 week treatment extension phase . This extension phase ass key safety efficacy measure .</brief_summary>
	<brief_title>A Safety Study Comparing LY2140023 Atypical Antipsychotic Standard Treatment Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Clinical diagnosis schizophrenia Patients , investigator 's opinion , must require switch another antipsychotic medication clinically indicated initiation antipsychotic agent Patients must willing able hospitalize , remain hospitalized ( already hospitalize ) , 17 day The investigator expect , time enrollment , patient able discharge hospital first 2 week active treatment Disease symptom must meet certain range assess clinician Patients must evidence functional impairment ( i.e . social vocational deficiency ) Patients must consider reliable , level understanding sufficient perform test examination require protocol , willing perform study procedures Patients must able understand nature study give informed consent Patients actively suicidal Patients pregnant nursing Patients electroconvulsive therapy ( ECT ) within 3 month screen ECT time study Patients uncorrected narrowangle glaucoma , seizure , uncontrolled diabetes , certain disease liver , uncontrolled thyroid condition serious unstable illness Patients Parkinson 's disease , psychosis relate dementia relate disorder Patients know Human Immunodeficiency Virus positive ( HIV+ ) status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>